Table 3 Multivariate survival analysis in patients

Preoperative PSA (ng/ml)

 ≤ 20

Reference

Reference

 > 20

1.85 (0.76–3.88)

0.163

2.08 (0.88–3.05)

0.219

Gleason score^a

 ≤ 6

Reference

Reference

7

1.15 (0.74–2.16)

0.061

2.28 (1.19–3.96)

0.029

 ≥ 8

2.55 (1.28–4.04)

0.033

1.96 (1.33–3.89)

0.026

Therapeutic methods

Neo CAB + Post ADT

Reference

Reference

Neo CAB + Post ADT + Post Che

1.57 (0.63–2.63)

0.673

0.96 (0.90–1.38)

0.363

Neo CAB + Post ADT + Post Rad

2.89 (0.55–5.01)

0.419

1.42 (0.79–1.78)

0.186

Neo Che + Post ADT + Post Che

1.80 (0.79–2.61)

0.309

1.17 (1.02–2.71)

0.041

Local lymph node status^a

pN0

Reference

Reference

pN1

3.52 (1.57–7.38)

0.006

2.60 (1.47–3.38)

0.011

Seminal vesicle status^a

Negative

Reference

Reference

Positive

2.16 (0.76–5.04)

0.266

0.89 (0.61–1.58)

0.068

Surgical margins^a

Negative

Reference

Reference

Positive

1.26 (0.58–2.51)

0.075

2.24 (0.58–3.06)

0.421

Invasion depth of bladder wall^a

Non-muscle-invasion

Reference

Reference

Muscle-invasion

4.75 (1.37–7.53)

 < 0.001

1.46 (1.06–3.02)

0.020